IMUX stock

Immunic Inc (IMUX) financials · $79.5M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Immunic Inc (IMUX) $79.5M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$103.2M-$98.1M
Net Income-$97.2M-$100.5M
EPS (Diluted)-$0.62N/A
Cached annual balance sheet
LineFY2025FY2024
Total Assets$24.1M$40.9M
Current Assets$22.9M$39.3M
Cash & Equivalents$15.5M$35.7M
PP&E$608.0K$545.0K
Total Liabilities$30.7M$22.4M
Current Liabilities$30.6M$22.2M
Shareholders' Equity-$6.67M$18.4M
Retained Earnings-$608.6M-$511.4M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$85.8M-$84.8M
CapEx$161.0K$264.0K
Investing Cash Flow-$161.0K-$264.0K
Financing Cash Flow$65.6M$74.5M
Net Change in Cash-$20.2M-$11.0M
Free Cash Flow-$86.0M-$85.0M
These statements as JSON? API free 100/day

FAQ

What is IMUX P/E and revenue?

Immunic Inc (IMUX) $79.5M cap.

What is IMUX revenue?

IMUX income-statement cache has no revenue figure yet.

Is IMUX profitable?

Immunic Inc last cached net income is -$97.2M (FY2025).

What are IMUX total assets?

Immunic Inc last cached total assets are $24.1M (FY2025).

What is IMUX free cash flow?

Immunic Inc last cached free cash flow is -$86.0M (FY2025).

Not investment advice. Cached statements, not a live tape.